Push to subsidise insulin pumps for type 2

Insulin pumps and their consumables should be subsidised for patients with long-standing type 2 diabetes on insulin who have suboptimal control, says an Australian endocrinologist.

Dr Katherine Benson, who practises at Sydney’s Concord Hospital, says 12-month data from the OpT2mise trial shows insulin pump therapy is a safe and effective option for patients with type 2 diabetes.

The study randomised